Medical Marijuana, Inc.’s “420” News: Hemp Brands and Investments Capture Attention of Fox Business, CNN Money, Yahoo Beauty and More

Mainstream News Reports Shine Light on MJNA’s Position in the Estimated Multibillion-Dollar U.S. Market, Demystify Cannabidiol (CBD) and Cannabigerol (CBG), and Educate Masses on Cannabis

Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded U.S. cannabis stock, is pleased to announce to the Company’s shareholders and the public that many of its portfolio brands and investments were featured in “420” mainstream news coverage.

The cannabis-focused content that featured MJNA’s brands and investments educated the masses on the open availability of hemp cannabidiol (CBD) oil products as well as the future access of cannabigerol (CBG) in retail products. A report by Fox Business quantifies the emerging U.S. market by stating, “Two new economic analyses project that the entire marijuana industry will be more than $40 billion over the next five to ten years and if cannabis becomes legal nationwide, the industry could hit $100 billion by 2050.

“From ‘420’ news reports, it is clear the public has an interest in knowledge about cannabis and retail products containing cannabinoids,” states Dr. Stuart Titus, Chief Executive Officer of Medical Marijuana, Inc. “This level of news coverage dispels decades-old myths, elevates the perception of today’s cannabis industry and accurately depicts the choices of cannabis products for consumers in the U.S. and around the world.”

News reports from “420” included:

Fox Business: on Why 4/20 is a $40 Billion Day

Yahoo Beauty’s: Here’s Why You Might Want to Slather Marijuana On

CNN Money: Cotton candy, toothpicks, pet gel -- these products are all made from marijuana

The Coveteur: Why Marijuana Needs to Be Part of Your Beauty Routine Now Can Marijuana Save Your Skin — And Your Sex Life? Inside the New Topical Cannabis Phenomenon


MJNA’s brands and investments featured in “420” news reports included:

Cannabis Beauty Defined™ available through Kannaway

Kánnactiv™ by Kannalife Sciences, Inc.

Oraximax™ by AXIM® Biotechnologies, Inc. (OTC: AXIM)


Recently, media coverage of the national debate on cannabis reform within Mexico has led to a change in attitude toward cannabis by Mexico's President Enrique Pena Nieto. Formerly a staunch opponent of cannabis legalization -- he reversed course with an epic pronouncement at the United Nations Special Assembly focused on the global battle on drug policy and cannabis reform earlier this week. "I am giving voice to those who have (in public forums) expressed the necessity of changing the regulatory framework to authorize the use of marijuana for medical and scientific purposes," President Nieto told the U.N. on Tuesday, April 19.

Titus concludes, “Education and compassion are essential to achieving global acceptance of and access to cannabis. Mexico’s President Nieto shows a wonderful example of the science and national debate leading the way toward change. Certainly cannabis was a deciding factor in the recent election of the new Canadian Prime Minister Justin Trudeau. For that reason, we are grateful to the media for taking the time to understand what MJNA has ultimately created: access to the world’s first and largest non-psychoactive CBD hemp oil pipeline.”

For more information on Medical Marijuana, Inc. and the portfolio company brands that it promotes, visit the Company’s website at



These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

For further information, please contact:

Public Relations contact:

Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829-0070

Corporate Contact:

Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)

Investor Relations:

Nicholas R. Massalas
Director of Business Development
Medical Marijuana Inc.
OTC Symbol: MJNA
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6505

About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit


The Company is committed to consistently providing the highest-quality CBD hemp oil products on the market. To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.